התחברות ל-baba News

חשבון אחד לאתר, לאייפון ולאנדרואיד — המנוי נשאר איתכם.

או קוד במייל

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. תנאי המנוי.

המנוי פותח גם את האפליקציה.

Search stories

הקלידו לפחות שני תווים. התוצאות מגיעות מכל המערכות ש-baba קורא.

to move · to open · esc to close

מסוף חי

התחברות ל-baba News

Sign in to keep asking. News Plus removes the daily limit.

או קוד במייל

לראות את התמונה המלאה

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. תנאי המנוי.

המנוי פותח גם את האפליקציה.

השוואת הסיקור המלא ב-2 מקורות

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

מאת אביבית מיסניקוב
Health11:12 · Jun 18

Experimental drug may help preserve muscle during weight loss injections

MakoCenter
Translated & summarized from Mako by baba
The story · English

A trial drug called Apitegromab may help people losing weight on popular obesity injections keep more muscle mass. The study, published in Nature Medicine, found that participants taking the experimental treatment alongside a weight-loss drug preserved about 1.9 kilograms more lean mass than those on the weight-loss drug alone, while still losing weight.

The research involved 102 adults, most of them women. In the Apitegromab and Mounjaro group, the extra preserved lean mass was about 55% higher than in the comparison group. Researchers also said lean mass accounted for only 14.6% of total weight loss among patients receiving the new drug, a lower share than is often seen with medications such as Wegovy and Mounjaro, where roughly a third of lost weight may come from muscle.

Apitegromab is currently available only in clinical trials and is given by intravenous infusion. It works by blocking a protein involved in muscle breakdown, and it is also being studied for other muscle diseases, including spinal muscular atrophy, or SMA. The company developing it is also considering a self-injection pen version similar to current weight-loss shots.

Experts said the findings are encouraging but preliminary. Dr. Marie Sparckly of the University of Cambridge called them “a promising early piece of evidence,” but not proof of clinical benefit, and said larger, longer studies are needed to determine whether preserving muscle improves strength and quality of life. Dr. Brendan Gabriel of the University of Aberdeen said the treatment may not be needed by everyone, but could help people who lose muscle quickly.

Dr. Raz Hagal, who heads a medical obesity treatment center, stressed that weight-loss drugs themselves do not directly cause muscle loss, but rapid weight reduction can, especially without proper nutrition and exercise. He said obesity treatment must be medically supervised, with a doctor, dietitian or clinical nutritionist, and sometimes a tailored exercise plan focused on strength training and adequate protein intake.

Read the original at Mako
Full coverage · 2 outlets
100% centerFirst: Mako · Jun 18

The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.

Center 2
Related stories · 5

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

פתיחת המסוף החי